Xylem is trading 4.3% up today at $125.33 after reporting a strong second-quarter 2026 earnings beat and surging demand indicators.
- The company posted adjusted EPS of $1.46, representing a 16% year-over-year increase that surpassed consensus estimates.
- Organic orders jumped 41% alongside expanding margins, signaling robust future growth prospects for the firm.
- Shares are currently outperforming a mixed broader market as investors react positively to the updated earnings and demand outlook.